Certified Global Research Member
Key Questions Answered
- Global Market Outlook
- In-depth analysis of global and regional trends
- Analyze and identify the major players in the market, their market share, key developments, etc.
- To understand the capability of the major players based on products offered, financials, and strategies.
- Identify disrupting products, companies, and trends.
- To identify opportunities in the market.
- Analyze the key challenges in the market.
- Analyze the regional penetration of players, products, and services in the market.
- Comparison of major players’ financial performance.
- Evaluate strategies adopted by major players.
- Recommendations
Why Choose Market Research Future?
- Vigorous research methodologies for specific market.
- Knowledge partners across the globe
- Large network of partner consultants.
- Ever-increasing/ Escalating data base with quarterly monitoring of various markets
- Trusted by fortune 500 companies/startups/ universities/organizations
- Large database of 5000+ markets reports.
- Effective and prompt pre- and post-sales support.
The multifaceted nature of the Spina Bifida market is marked by many factors including condition prevalence rates and advancements in medical technology. Over the years, people have come to know more about spinal cord disorders such as spina bifida which has necessitated the need for better treatment options as well as therapies. This has led to an increased number of cases of spina bifida globally; and endorses market dynamics. In addition, there is increasing awareness among people that calls for early diagnosis and interventions leading to the requirement of diagnostic tools and medical intercessions.
Research and development by healthcare industry have greatly shaped the Spina Bifida market. This has resulted in new treatments through search for the cause and risk factors associated with it. Recently, there have been changes in the environment caused by gene therapy and regenerative medicine thus being more accurate as well as efficient in handling such cases which affect market dynamics. Also, personalized medicine is becoming widespread targeting medication at patients according to their specific genetic formulas.
Spina Bifida Market Dynamics are also influenced by Government initiatives and healthcare policies. Increased funding towards research, public health campaigns alongside screening newborns for Spina Bifida continue to drive this market further. Regulatory frameworks that support faster approval of innovative therapies facilitate rapid market expansion. Thus whether governments work together with non-governmental organizations (NGOs) or other players from private sector can be seen as a collective effort towards mitigating problems posed by Spina Bifida.
On another hand, advancements in medical equipment technology plus surgical procedures directly affect Spina Bifida Market. There are various types of minimally invasive surgeries while better imaging technologies coupled with novel medical devices expand patient’s treatment options hence improved clinical outcomes. These technological advances not only broaden therapeutic choices but also attract investment from both existing players and emerging players in healthcare investment category that grow the overall market.
Spina Bifida markets tend to be more influenced by countries’ economic landscapes and healthcare infrastructures than anything else in terms of affecting their local business environment. For example, the differences in access to health services affect uptake of innovations or utilization of technology-enhanced therapies like virtual reality-based spinal implants. At present, such gaps can only be addressed through cooperation between international organizations working on healthcare issues and pharmaceutical companies involved in manufacturing various spina bifida treatment options as well as medical practitioners.
Spina Bifida Market Highlights:
Spina Bifida Market Overview
Spina Bifida Market Size was valued at USD 2.5 Billion in 2023. The Global Spina Bifida industry is projected to grow from USD 2.6 Billion in 2024 to USD 2.9 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 10.10% during the forecast period (2024 - 2032). Spina bifida is a congenital disorder that results in the malformation of the spinal cord. The condition is more common among Hispanics and whites, and the prevalence females are more likely to get affected than males.
On considering historical prevalence data of spina bifida in northeast China, during 2006-2015, it is found that a total of 2,029 cases of spina bifida were identified from 3,248,954 live births i.e. 6.25/10,000 live births. The disease is found to be highly prevalent in Chaoyang, Fuxin, and Huludao cities of China. According to the 2013 study conducted by Healthcare Cost and Utilization Project, hospitalization cost related to spina bifida was more than USD 600 million in 2013 for people of all ages.
It is noted that rising technological advancements is the key factor driving the spina bifida market. With the rising awareness about the disease, market players are coming up with innovations owing to technological advancements. For instance, in Nov 2015, B. Braun Melsungen AG announced the launch of Ster-ASSIST Sterile Peripheral IV Catheter Insertion Kit. In the same year, Medtronic acquired Twelve, Inc., a developer of trans-catheter mitral valve replacement device.
Various other factors such as growing awareness, increased incidence of spina bifida, related complications, unmet medical needs, improving regulatory framework, increasing adoption rate, increasing government assistance, and rising funding and reimbursement are continuously contributing to the growth of the spina bifida market.
Despite these drivers, there are some issues associated with spina bifida market. The cost of treatment, side-effects of surgeries, and poor healthcare system in low and middle-income countries may hinder the growth of the market to an extent.
Research Methodology
Sources: Annual reports, Press release, White paper, and Company presentation
Intended Audience
- Pharmaceutical Companies
- Medical Device Companies
- Research and Development (R&D) Companies
- Diagnostic Laboratories
- Government Research Institute
- Academic Institutes and Universities
Spina Bifida Market Segmentation
The spina bifida market is segmented on the basis of type, diagnosis, treatment, and end user.
On the basis of the type, the spina bifida market is classified as occulta, closed neural tube defects, meningocele, and myelomeningocele.
On the basis of the diagnosis, the spina bifida market is classified as blood tests, ultrasound, amniocentesis, and others. The blood tests segment is further classified as maternal serum alpha-fetoprotein (MSAFP) test, test to confirm high AFP levels, and other blood tests.
On the basis of the treatment, the spina bifida market is classified as medical procedure, surgery, oral medications, and others. The medical procedure is further segmented into urinary catheterization, urinary diversion, and enema. The surgery is further segmented into spine surgery, fetal endoscopic surgery, spinal fusion, suprapubic cystostomy, and caesarean section. The oral medications is further segmented into antibiotics, and others.
On the basis of the end user, the spina bifida market is segmented into hospitals, clinics, diagnostic centers, drug stores, pharmacies, and others.
Spina Bifida Market Regional Analysis
The Americas dominate the spina bifida market owing to the rising occurrence of spina bifida in this region, and technological advancements. According to the statistics suggested by Centers for Disease Control and Prevention (CDC), around 1,500 babies are born with spina bifida every year in the United States. It is also reported that Hispanic women are the most vulnerable population for this disease as compared to non-Hispanic black or non-Hispanic white women.
Europe holds the second position in the spina bifida market. It is expected that the government support towards research & development expenditure, and amendments in reimbursement policies in the healthcare is likely to drive the European spina bifida market.
Asia Pacific is the fastest growing spina bifida market owing to a huge patient pool and development in healthcare technology. Healthcare expenditure is found to be improving in various Asia Pacific regions. According to the data suggested by Australian Institute of Health and Welfare during the year 2015-16, the total health expenditure was USD 170.4 billion i.e. 3.6% higher than the expenditure of 2014-2015.
The Middle East & Africa holds the lowest share of the global market due to low development, lack of technical knowledge, and poor medical facilities.
Spina Bifida Market Key Players
Some of key the players in the spina bifida market are:
- B. Braun Melsungen AG
- Boston Scientific
- C.B. Fleet
- C.R. Bard, Inc.
- Coloplast A/S
- ConvaTec Group plc
- Cook Medical
- Covidien Private Ltd.
- Dynarex Corporation
- Ethicon
- Fujifilm
- Hollister Incorporated
- KARL STORZ
- Medline Industries
- Medtronic plc
- Olympus
- Pacific Hospital Supply Co., Ltd.
- Smith & Nephew
- Stryker
- Teleflex Incorporation
- Wellspect Healthcare
Leading companies partner with us for data-driven Insights
Kindly complete the form below to receive a free sample of this Report
Tailored for You
- Dedicated Research on any specifics segment or region.
- Focused Research on specific players in the market.
- Custom Report based only on your requirements.
- Flexibility to add or subtract any chapter in the study.
- Historic data from 2014 and forecasts outlook till 2040.
- Flexibility of providing data/insights in formats (PDF, PPT, Excel).
- Provide cross segmentation in applicable scenario/markets.
